Experior 10 (Canada)

Lubabegron Premix (as Lubabegron Fumarate)

DIN 02482061

FOR VETERINARY USE ONLY

FOR USE IN FEEDS FOR CATTLE FED IN CONFINEMENT FOR SLAUGHTER ONLY

Active Ingredient

Experior 10 Indications

For reduction of ammonia gas emissions per kilogram of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Effectiveness has not been demonstrated when fed for less than 14 days.

Ammonia gas emissions were measured for individual animals or small groups of animals held in environmentally controlled facilities. Based on existing information, reliable predictions of the reduction of ammonia gas emissions cannot be made on a herd, farm, or larger scale.

Increased rate of weight gain, improved feed efficiency, and increased carcass leanness have not been demonstrated with this product.

Note:

Lubabegron may contribute to decreased marbling scores when fed for the maximum duration of 91 days.

Dosage and Administration

Administer at a dietary concentration of 1.5 to 5.5 grams of lubabegron per tonne of feed (1.5 to 5.5 ppm), on a 100% dry matter basis.

IMPORTANT:

1. For use in manufactured feeds only.

2. Must be thoroughly mixed in feeds before use.

3. Do not feed undiluted.

4. Do not feed as top dressing.

MIXING DIRECTIONS:

Thoroughly mix 150 g to 550 g of Experior 10 premix per tonne (1,000 kg) of complete feed (100% dry matter basis) to obtain a concentration of 1.5 to 5.5 g/tonne (1.5 to 5.5 ppm) of lubabegron in the feed. To ensure adequate mixing, an intermediate blending step should be performed prior to manufacturing a complete feed.

FEEDING DIRECTIONS:

Feed continuously to beef steers and heifers fed in confinement for slaughter as the sole ration during the last 14 to 91 days prior to slaughter.

Warnings

1. No withdrawal period is required in beef cattle when treated according to the label.

2. Do not use in calves to be processed for veal.

3. Do not use in lactating dairy cattle.

4. The active ingredient in Experior 10, lubabegron, is a selective beta-adrenergic modulator (agonist and antagonist). Individuals with cardiovascular disease should exercise special caution to avoid exposure.

5. Experior 10 poses a low dust potential under usual conditions of handling and mixing. When mixing and handling Experior 10, avoid inhalation, oral exposure and direct contact with eyes or skin. Use protective clothing, impervious gloves and an approved dust mask. Operators should wash thoroughly with soap and water after handling.

6. If accidental eye or skin contact occurs, immediately rinse thoroughly with water; if wearing contact lenses, rinse eyes first, then remove contact lenses and continue to rinse for 5-20 minutes. If irritation persists, seek medical attention.

7. Not for use in humans.

8. Keep out of reach of children.

CAUTIONS:

1. Do not use in animals intended for breeding because safety and effectiveness have not been evaluated in these animals.

2. Do not use concurrently with beta-adrenergic agonists such as ractopamine and zilpaterol.

3. Do not allow horses or other equines access to feed containing Experior 10.

4. A decrease in dry matter intake may be noticed in some animals.

Adverse Reactions

To report suspected adverse drug events or for technical assistance, contact Elanco at 1-800-265-5475.

Storage

Store at or below 25°C. Excursions permitted to 30°C.

Experior, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2022 Elanco or its affiliates.

Elanco Canada Limited, 1919 Minnesota Court, Suite 401, Mississauga, Ontario L5N 0C9

CPN: 1231232.2